公司資料
TherapeuticsMD 股價、新聞與催化劑
- 股票代碼:
- TXMD
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
2.01 USD (-2.90%)
收盤價
最後更新: 2026年8月17日
23.6M USD
市值
股價為何變動
As of Aug 17, 2026, TXMD closed down 2.90% at $2.01. No new same-company headline was identified in the current news window.
公司概覽
Pharmaceutical Royalty Company
TherapeuticsMD owns rights to royalties and license revenue from women's health pharmaceutical products rather than operating a broad internal commercial organization.
Royalty Portfolio Model
Revenue is primarily tied to products licensed under the Mayne agreement, giving TherapeuticsMD exposure to partner sales without directly funding commercialization. The business focuses on collecting contractual economics and preserving remaining intellectual property rights.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。